Literature DB >> 11997070

Clinical features and neuropathological findings of familial amyotrophic lateral sclerosis with a His46Arg mutation in Cu/Zn superoxide dismutase.

Takekazu Ohi1, Kazuko Saita, Shinji Takechi, Kazuki Nabesima, Hirofumi Tashiro, Kazutaka Shiomi, Seiichiro Sugimoto, Tomotoshi Akematsu, Tatsuo Nakayama, Toru Iwaki, Shigeru Matsukura, Kyoko Saita.   

Abstract

We examined the characteristic clinical features of one family of familial amyotrophic lateral sclerosis (FALS) with a His46Arg mutation in the enzyme Cu/Zn superoxide dismutase-1 (SOD1). The disease duration for this family was 18.1 +/- 13.2 (mean +/- S.D.) years, with the age at onset being 39.7 +/- 10.5 years old (mean +/- S.D.). The initial sign was distal weakness of the unilateral lower limb, extending to the lower limb of the other side. A wheel chair became necessary at 9.8 +/- 3.2 years after the onset. Upper limb weakness started at 15.5 +/- 8.9 years following from the onset. An autopsy was performed on a 71-year-old woman of the family with the mutation. Her disease duration was 47 years, and she died of pneumonia. She had no clear upper motor neuron involvement. Bulbar sign and respiratory muscle weakness had developed 2 years before her death. Neuropathological findings showed degeneration of corticospinal tracts, anterior/posterior spinocerebellar tracts, posterior columns, and Clarke's columns. There were few anterior horn cells in the lumbar spinal cord and no Lewy body-like hyaline inclusion bodies in these remaining anterior horn neurons. This is the first autopsy report of FALS with a His46Arg mutation in the SOD1 enzyme.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11997070     DOI: 10.1016/s0022-510x(02)00054-0

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  4 in total

1.  Interaction of amyotrophic lateral sclerosis (ALS)-related mutant copper-zinc superoxide dismutase with the dynein-dynactin complex contributes to inclusion formation.

Authors:  Anna-Lena Ström; Ping Shi; Fujian Zhang; Jozsef Gal; Renee Kilty; Lawrence J Hayward; Haining Zhu
Journal:  J Biol Chem       Date:  2008-05-30       Impact factor: 5.157

2.  Interpretation of electrodiagnostic findings in sporadic progressive muscular atrophy.

Authors:  J Visser; M de Visser; R M Van den Berg-Vos; L H Van den Berg; J H J Wokke; J M B V de Jong; H Franssen
Journal:  J Neurol       Date:  2008-05-19       Impact factor: 4.849

3.  Superoxide dismutase 1 encoding mutations linked to ALS adopts a spectrum of misfolded states.

Authors:  Mercedes Prudencio; David R Borchelt
Journal:  Mol Neurodegener       Date:  2011-11-17       Impact factor: 14.195

4.  Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival.

Authors:  Qi Wang; Joshua L Johnson; Nathalie Y R Agar; Jeffrey N Agar
Journal:  PLoS Biol       Date:  2008-07-29       Impact factor: 8.029

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.